Dr Maciej Debowski
on January 9, 2017
In response to the anti-angiogenic chemotherapy (bevacizumab), the post-treatment MRI shows significant reduction in enhacement, mass affect and t...”
View full size version of Pseudoresponse to bevacizumab in high grade glioma
See the case: Pseudoresponse to bevacizumab in high grade glioma
Updating… Please wait.
Unable to process the form. Check for errors and try again.
Thank you for updating your details.